Practical Geriatrics ›› 2025, Vol. 39 ›› Issue (5): 450-455.doi: 10.3969/j.issn.1003-9198.2025.05.004
Previous Articles Next Articles
DUAN Jianfeng, YU Wenkui
Received:
2025-03-24
Online:
2025-05-20
Published:
2025-05-20
Contact:
YU Wenkui, Email: yudrnj@163.com
CLC Number:
DUAN Jianfeng, YU Wenkui. Gut microbiota and critical illness in the elderly[J]. Practical Geriatrics, 2025, 39(5): 450-455.
[1] VALLET H, SCHWARZ G L, FLAATTEN H, et al. Mortality of older patients admitted to an ICU: a systematic review[J]. Crit Care Med,2021,49(2):324-334. [2] CLAESSON M J, CUSACK S, O'SULLIVAN O, et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly[J]. Proc Natl Acad Sci USA, 2011,108( Suppl 1):4586-4591. [3] VICTORIA M, ELENA V B, AMPARO G N, et al. Gut microbiota alterations in critically ill older patients: a multicenter study[J]. BMC Geriatr,2022,22(1):373. [4] BATTAGLINI D, TORRES A. Gut microbiota and its impact on critical illness[J]. Curr Opin Crit Care,2025,31(2):189-197. [5] ODAMAKI T, KATO K, SUGAHARA H, et al. Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study[J]. BMC Microbiol, 2016,16:90. [6] BLAUT M. Gut microbiota and energy balance: role in obesity[J]. Proc Nutr Soc,2015,74(3):227-234. [7] BHATTARAI Y, WILLIAMS B B, BATTAGLIOLI E J, et al. Gut microbiota-produced tryptamine activates an epithelial g-protein-coupled receptor to increase colonic secretion[J]. Cell Host Microbe,2018,23(6):775-785.e5. [8] XU H, FANG F, WU K, et al. Gut microbiota-bile acid crosstalk regulates murine lipid metabolism via the intestinal FXR-FGF19 axis in diet-induced humanized dyslipidemia[J]. Microbiome,2023,11(1):262. [9] WON T H, ARIFUZZAMAN M, PARKHURST C N, et al. Host metabolism balances microbial regulation of bile acid signalling[J]. Nature,2025,638(8049):216-224. [10] MINIET A A, GRUNWELL J R,COOPERSMITH C M. The microbiome and the immune system in critical illness[J]. Curr Opin Crit Care,2021,27(2):157-163. [11] CLEMENTE J C, URSELL L K, PARFREY L W, et al. The impact of the gut microbiota on human health: an integrative view[J]. Cell,2012,148(6):1258-1270. [12] SCHNUPF P, GABORIAU-ROUTHIAU V, SANSONETTI P J, et al. Segmented filamentous bacteria, Th17 inducers and helpers in a hostile world[J]. Curr Opin Microbiol,2017,35:100-109. [13] PLUZNICK J L, PROTZKO R J, GEVORGYAN H, et al. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation[J]. Proc Natl Acad Sci USA,2013,110(11):4410-4415. [14] XU Y, DUAN J, WANG D, et al. Akkermansia muciniphila alleviates persistent inflammation, immunosuppression, and catabolism syndrome in mice[J]. Metabolites,2023,13(2):194. [15] KAYAMA H, TAKEDA K. Polysaccharide a of bacteroides fragilis: actions on dendritic cells and T cells[J]. Mol Cell,2014,54(2):206-207. [16] MARTINEZ F A C, BALCIUNAS E M, CONVERTI A, et al. Bacteriocin production by Bifidobacterium spp. A review[J]. Biotechnol Adv, 2013,31(4):482-488. [17] POWELL N, WALKER M M, TALLEY N J. The mucosal immune system: master regulator of bidirectional gut-brain communications[J]. Nat Rev Gastroenterol Hepatol,2017,14(3):143-159. [18] BONAZ B, BAZIN T, PELLISSIER S. The vagus nerve at the interface of the microbiota-gut-brain axis[J]. Front Neurosci,2018,12:49. [19] TIWARI S, PARAMANIK V. Role of probiotics in depression: connecting dots of gut-brain-axis through hypothalamic-pituitary adrenal axis and tryptophan/kynurenic pathway involving indoleamine-2,3-dioxygenase[J]. Mol Neurobiol,2025.Online ahead of print. [20] LIAO H, LI H, BAO H, et al. Short chain fatty acids protect the cognitive function of sepsis associated encephalopathy mice via GPR43[J]. Front Neurol,2022,13:909436. [21] XU K, GAO X, XIA G, et al. Rapid gut dysbiosis induced by stroke exacerbates brain infarction in turn[J]. Gut,2021:gutjnl-2020-323263.. [22] ANAND S, MANDE S S. Diet, microbiota and gut-lung connection[J]. Front Microbiol, 2018,9:2147. [26] ELADHAM M W, SELVAKUMAR B, SAHEB SHARIF-ASKARI N, et al. Unraveling the gut-Lung axis: exploring complex mechanisms in disease interplay[J]. Heliyon,2024,10(1):e24032. [24] LI X, SHANG S, WU M, SONG Q ,et al. Gut microbial metabolites in lung cancer development and immunotherapy: Novel insights into gut-lung axis[J]. Cancer Lett,2024,598:217096. [25] MCALEER J P , KOLLS J K. Contributions of the intestinal microbiome in lung immunity[J]. Eur J Immunol,2018,48(1):39-49. [26] REN Z, ZHENG Z,FENG X. Role of gut microbes in acute lung injury/acute respiratory distress syndrome[J]. Gut Microbes,2024,16(1):2440125. [27] ADDOLORATO G, PONZIANI F R, DIONISI T, et al. Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease[J]. Liver Int,2020,40(4):878-888. [28] CHEN Y, JI F, GUO J, et al. Dysbiosis of small intestinal microbiota in liver cirrhosis and its association with etiology[J]. Sci Rep,2016,6:34055. [29] TILG H, ADOLPH T E,TRAUNER M. Gut-liver axis: pathophysiological concepts and clinical implications[J]. Cell Metab,2022,34(11):1700-1718. [30] Kim G, Chen Z, Li J, et al. Gut-liver axis calibrates intestinal stem cell fitness[J]. Cell, 2024,187(4):914-930.e20. [31] ZHU W, GREGORY J C, ORG E, et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk[J]. Cell,2016,165(1):111-124. [32] ANDRADE-OLIVEIRA V, AMANO M T, CORREA-COSTA M, et al. Gut bacteria products prevent AKI induced by ischemia-reperfusion[J]. J Am Soc Nephrol,2015,26(8):1877-1888. [33] WU J, REN W, CHEN L, et al. Age-related changes in the composition of intestinal microbiota in elderly chinese individuals[J]. Gerontology,2022,68(9):976-988. [34] SCHLECHTE J, ZUCOLOTO A Z, YU I L, et al. Dysbiosis of a microbiota-immune metasystem in critical illness is associated with nosocomial infections[J]. Nat Med, 2023,29(4):1017-1027. [35] MCDONALD D, ACKERMANN G, KHAILOVA L, et al. Extreme dysbiosis of the microbiome in critical illness[J]. mSphere,2016,1(4): e00199-16. [36] LANKELMA J M, VAN VUGHT L A, BELZER C, et al. Critically ill patients demonstrate large interpersonal variation in intestinal microbiota dysregulation: a pilot study[J]. Intensive Care Med,2017,43:59-68. [37] THEVARANJAN N, PUCHTA A, SCHULZ C, et al. Age-associated microbial dysbiosis promotes intestinal permeability, systemic inflammation, and macrophage dysfunction [J]. Cell Host Microbe, 2017,21(4):455-466.e4. [38] NIKOLICH-ŽUGICH J. The twilight of immunity: emerging concepts in aging of the immune system[J]. Nat Immunol,2018,19(1): 10-19. [39] MOHAMMADI F, RUDKOWSKA I. Dietary lipids, gut microbiota, and their metabolites: insights from recent studies[J]. Nutrients, 2025,17(4): 639. [40] LADOPOULOS T, GIANNAKI M, ALEXOPOULOU C, et al. Gastrointestinal dysmotility in critically ill patients[J]. Ann Gastroenterol,2018,31(3):273-281. [41] MORON R, GALVEZ J, COLMENERO M, et al. The importance of the microbiome in critically ill patients: role of nutrition[J]. Nutrients,2019,11(12): 3002. [42] SALAMEH T J, ROTH K, SCHULTZ L, et al. Gut microbiome dynamics and associations with mortality in critically ill patients[J]. Gut Pathog,2023,15(1):66. [43] ADELMAN M W, WOODWORTH M H, LANGELIER C, et al. The gut microbiome's role in the development, maintenance, and outcomes of sepsis[J]. Crit Care,2020,24(1):278. [44] MILLER W D, KESKEY R, ALVERDY J C. Sepsis and the microbiome: a vicious cycle[J]. J Infect Dis,2021,223(12 Suppl 2):S264-s269. [45] XIONG D, GENG H, LV X, et al. Inflammatory response and anti-inflammatory treatment in persistent inflammation-immunosuppression-catabolism syndrome (PICS)[J]. J Inflamm Res,2025,18:2267-2281. [46] DAVISON J M, WISCHMEYER P E. Probiotic and synbiotic therapy in the critically ill: state of the art[J]. Nutrition,2019,59:29-36. [47] WOZNIAK H, BECKMANN T S, FRÖHLICH L, et al. The central and biodynamic role of gut microbiota in critically ill patients[J]. Crit Care, 2022,26(1):250. [48] SCHÖRGHUBER M, FRUHWALD S. Effects of enteral nutrition on gastrointestinal function in patients who are critically ill[J]. Lancet Gastroenterol Hepatol,2018,3(4):281-287. [49] HE S, LIN F, HU X, et al. Gut microbiome-based therapeutics in critically ill adult patients-a narrative review[J]. Nutrients,2023,15(22):4734. [50] KESKEY R, CONE J T, DEFAZIO J R,et al. The use of fecal microbiota transplant in sepsis[J]. Transl Res, 2020,226:12-25. [51] PANCHE A N, DIWAN A D, CHANDRA S R. Flavonoids: an overview[J]. J Nutr Sci, 2016,5:e47. [52] LI J, ZHANG L, WU T, et al. Indole-3-propionic acid improved the intestinal barrier by enhancing epithelial barrier and mucus barrier[J]. J Agric Food Chem, 2021,69(5):1487-1495. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||